Dosage Charts  ›  Liraglutide
GLP-1 / Metabolic

Liraglutide Guide & Dosage Chart

A GLP-1 receptor agonist studied for glycemic control and weight.

Also known asVictoza / Saxenda
Routesubcutaneous
Liraglutide — Dosage chart
Every row cited
GoalDoseFrequencyDurationEvidenceSource
Obesity treatment in children aged 6 to <12 years 3 mg 1x/day 56 weeks Clinical PMID 39258838
Weight loss in adults with obesity (active comparator dose in phase 2 trial) 3 mg 1x/day 52 weeks Clinical PMID 30122305
Weight regain or insufficient weight loss after metabolic bariatric surgery 3 mg 1x/day per trial Clinical PMID 39134066
Type 2 diabetes glycemic control and weight loss (active comparator dose) 1.2 mg 1x/day 30 weeks Clinical PMID 31539622
For research and educational use only. Not medical advice.

Liraglutide FAQ

What is the typical Liraglutide dosage?
In research, Liraglutide has been studied at 3 mg 1x/day for Obesity treatment in children aged 6 to <12 years (56 weeks). See the chart above for every studied protocol, each cited.
How do you reconstitute Liraglutide?
Mix the lyophilized Liraglutide with bacteriostatic water, then use the concentration to find your draw volume. The calculator on this page does the math for you.
Is Liraglutide dosing backed by research?
Yes — every dose on this chart maps to a peer-reviewed source. Figures we cannot anchor to a study are left out. Liraglutide is a research compound for laboratory use only.